However, novel kidney biomarkers (Cys C, NGAL, KIM-1, H-FABP and NAG) have recently been evaluated in CHF patients, and their serum levels have prognostic value for not only renal outcomes but also cardiovascular outcomes7. Here, FABP3 is linked to congestive heart failure.